Welcome to the Lady Davis Institute
The Lady Davis Institute (LDI) is the research arm of Montreal's Jewish General Hospital, a teaching hospital of McGill University.
Founded in 1969, the LDI is one of Canada's leading health research institutes. Important discoveries which have contributed to the health and well-being of patients in Quebec, Canada, and around the world, have been made by LDI researchers in the areas of HIV/AIDS, aging, cancer, vascular disease, epidemiology, and psychosocial science. There are currently more than 117 full-time researchers at the LDI, of whom 70 are primarily lab-based, 21 investigate psychosocial aspects of disease, 26 are in epidemiology. In addition, there are 124 associate investigators. 

Pharma and Biotech:
Collaborate with the LDI
News from the LDI
Association between certain antidepressants and the risk of intracranial bleeding
An investigation conducted at the Lady Davis Institute has shown that one of the effects of a particular type of antidepressant is to increase the risk of spontaneous intracranial hemorrhage.


Significant advance in understanding the disparity in prognosis between men and women in melanoma
Men with melanoma have a much poorer prognosis than women. Research conducted at the Lady Davis Institute has uncovered a biological mechanism to explain the phenomenon.


Copyright © 2010 Lady Davis Institute/Jewish General Hospital.
Created by Blue Lemon Media Inc.
Sitemap | Disclaimer